Toronto Dominion Bank’s CareDx CDNA Stock Holding History

Toronto Dominion Bank’s Portfolio CDNA Stock Details CDNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-100	Closed	-$700	–	1618
2023 Q3	$700	Hold	100	–	–	﹤0.01%	1465
2023 Q2	$1K	Buy	+100	New	+$834	﹤0.01%	1397

Other funds holding CDNA

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return

Toronto Dominion Bank's CDNA Position: Q4 2023 in Review

Toronto Dominion Bank sold out of CareDx (CDNA) in Q4 2023, closing a stake of 100 shares — an estimated $700 sold.

Toronto Dominion Bank first reported a position in CDNA in Q2 2023 and held it in 2 quarters. The position peaked at $1K in Q2 2023. 147 funds tracked by Wall St. Rank hold CDNA as of Q4 2023.

Toronto Dominion Bank reported no remaining CareDx position as of Q4 2023 after selling out during the quarter.
Toronto Dominion Bank sold 100 CareDx shares in Q4 2023, an estimated $700.
Toronto Dominion Bank first reported a position in CareDx in Q2 2023 and held it in 2 quarters.
Toronto Dominion Bank's CareDx position peaked at $1K in Q2 2023.
147 funds tracked by Wall St. Rank held CareDx as of Q4 2023.

Based on Toronto Dominion Bank's 13F filing for Q4 2023, filed 13 Feb 2024.